Skip to content

Public FDA record

Z-0955-2022: Inactivated macrolide-resistant Mycoplasma genitalium

Recall record Z-0955-2022 for Microbiologics Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0955-2022
Company in FDA record
Microbiologics Inc
FDA record creation date
Apr 19, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The QC process was not adequate for the specification range.

Source facts

Action
A customer letter, dated 03/24/2022, was issued to the impacted consignee via email. The consignee is instructed to destroy the product as it is now past its updated expiration date. The consignee is asked to complete the response form and submit to the recalling firm.
Initiated
2022-03-22
Root cause
Process control
Terminated
2023-01-09
Distribution
US Nationwide distribution in the states of NV and VT.
Recall number
Z-0955-2022
Recall status
Terminated
CDRH record ID
192791
FDA record created
2022-04-19
Recall event number
89887

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗